Acumen Pharmaceuticals, Inc.
ABOS
$1.11
$0.098.82%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -125.22% | -129.72% | -76.89% | -31.54% | -28.22% |
| Total Depreciation and Amortization | 12.82% | 12.50% | -15.09% | -15.38% | -20.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -19.90% | 56.18% | -85.09% | -1.80% | 161.25% |
| Change in Net Operating Assets | 35.79% | 525.28% | 382.23% | -17,045.83% | 643.73% |
| Cash from Operations | -227.34% | -90.59% | -41.77% | -75.52% | 25.79% |
| Capital Expenditure | 100.00% | 100.00% | -- | -- | 60.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 160.79% | 88.99% | 240.78% | 78.08% | -139.36% |
| Cash from Investing | 160.78% | 88.99% | 240.74% | 78.05% | -139.02% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | 97.69% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -128.97% | 11.72% | -- | -260.81% |
| Cash from Financing | -100.03% | -100.03% | 11.72% | -- | 596.32% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 108.71% | -294.70% | 2,899.73% | 61.70% | -2.00% |
